EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.
| Website | http://engeneic.com/ |
| Revenue | $5.2 million |
| Employees | 20 (20 on RocketReach) |
| Founded | 2001 |
| Competitors | Johnson & Johnson, Roche, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen +43 more (view full list) |
Looking for a particular EnGeneIC employee's phone or email?
EnGeneIC Questions
The EnGeneIC annual revenue was $5.2 million in 2026.
Nancy Mugridge is the VP, Alliances of EnGeneIC.
20 people are employed at EnGeneIC.
Top EnGeneIC Employees
-
Jennifer MacDiarmid
Joint-CEO and Director at EnGeneIC
Sydney, NSW, AU12 -
Nancy Mugridge
VP, Alliances at EnGeneIC
Sydney, NSW, AU11 -
11
-
Andrea Lee
Senior Finance Manager at EnGeneIC
Melbourne, VIC, AU12 -
Henrique Silva
Sr Clinical Research Associate at EnGeneIC
Sydney, NSW, AU2 -
Seán Ryan
Senior Manufacturing Engineer at EnGeneIC
Maroubra, NSW, AU1
G2Crowd Trusted
300K+
Plugin Users
